The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Insulin Syringes-Global Market Insights and Sales Trends 2025

Insulin Syringes-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1822881

No of Pages : 113

Ask Your Query
Synopsis
An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.
The global Insulin Syringes market size is expected to reach US$ 2151.9 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Syringes in various end use industries. The expanding demands from the Hospital, Homecare and Others,, are propelling Insulin Syringes market. 3/10 CC Syringe, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 1/2 CC Syringe segment is estimated at % CAGR for the next seven-year period.
The Insulin Syringes market is expected to be positively impacted by the COVID-19 pandemic. As patients with different health issues such as, diabetes and high blood pressure are at higher risk of getting affected by virus. It is found that the mortality rate is high in a patient with diabetes compared to the general population. The people having diabetes require continuous access to insulin (administrated with syringes or pens) and care.Thus, the adoption of insulin syringes and continuous glucose monitoring devices has increased for close monitoring and optimal management of diabetes. The major factor that contributes to the growth of the insulin syringes market include surge in aging population and increased number of diabetic patients globally. Furthermore, other factors such as favorable government policies related to insulin syringes are the key factors that drive the growth of the market. In addition, surge in incidence of obesity and people adopting an unhealthy lifestyle supplement the growth of market. Moreover, rise in prevalence of various chronic diseases such as type-1 and type-2 diabetes, is another major factor that boosts the market growth.

Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Syringes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Syringes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Syringes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Syringes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Syringes covered in this report include Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon Ltd, Ypsomed AG, Wockhardt Ltd, Medtronic Plc, Abbott Laboratories and Animas Corporation, etc.
The global Insulin Syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon Ltd
Ypsomed AG
Wockhardt Ltd
Medtronic Plc
Abbott Laboratories
Animas Corporation
F. Hoffmann-La Roche
BD
Terumo Corporation
Cardinal Health Inc
Medline Industries
Braun Melunsun
Nipro Medical Corporation
HMD Healthcare Ltd
Global Insulin Syringes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Syringes market, Segment by Type:
3/10 CC Syringe
1/2 CC Syringe
1 CC Syringe
Others
Global Insulin Syringes market, by Application
Hospital
Homecare
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Syringes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Insulin Syringes Market Overview
1.1 Insulin Syringes Product Overview
1.2 Insulin Syringes Market Segment by Type
1.2.1 3/10 CC Syringe
1.2.2 1/2 CC Syringe
1.2.3 1 CC Syringe
1.2.4 Others
1.3 Global Insulin Syringes Market Size by Type
1.3.1 Global Insulin Syringes Market Size Overview by Type (2018-2029)
1.3.2 Global Insulin Syringes Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insulin Syringes Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Syringes Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insulin Syringes Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insulin Syringes Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insulin Syringes Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insulin Syringes Sales Breakdown by Type (2018-2023)
2 Global Insulin Syringes Market Competition by Company
2.1 Global Top Players by Insulin Syringes Sales (2018-2023)
2.2 Global Top Players by Insulin Syringes Revenue (2018-2023)
2.3 Global Top Players by Insulin Syringes Price (2018-2023)
2.4 Global Top Manufacturers Insulin Syringes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Syringes Market Competitive Situation and Trends
2.5.1 Insulin Syringes Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Syringes Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Syringes as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Syringes Market
2.8 Key Manufacturers Insulin Syringes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Syringes Status and Outlook by Region
3.1 Global Insulin Syringes Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insulin Syringes Historic Market Size by Region
3.2.1 Global Insulin Syringes Sales in Volume by Region (2018-2023)
3.2.2 Global Insulin Syringes Sales in Value by Region (2018-2023)
3.2.3 Global Insulin Syringes Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insulin Syringes Forecasted Market Size by Region
3.3.1 Global Insulin Syringes Sales in Volume by Region (2024-2029)
3.3.2 Global Insulin Syringes Sales in Value by Region (2024-2029)
3.3.3 Global Insulin Syringes Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insulin Syringes by Application
4.1 Insulin Syringes Market Segment by Application
4.1.1 Hospital
4.1.2 Homecare
4.1.3 Others
4.2 Global Insulin Syringes Market Size by Application
4.2.1 Global Insulin Syringes Market Size Overview by Application (2018-2029)
4.2.2 Global Insulin Syringes Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insulin Syringes Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Syringes Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insulin Syringes Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insulin Syringes Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insulin Syringes Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insulin Syringes Sales Breakdown by Application (2018-2023)
5 North America Insulin Syringes by Country
5.1 North America Insulin Syringes Historic Market Size by Country
5.1.1 North America Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insulin Syringes Sales in Volume by Country (2018-2023)
5.1.3 North America Insulin Syringes Sales in Value by Country (2018-2023)
5.2 North America Insulin Syringes Forecasted Market Size by Country
5.2.1 North America Insulin Syringes Sales in Volume by Country (2024-2029)
5.2.2 North America Insulin Syringes Sales in Value by Country (2024-2029)
6 Europe Insulin Syringes by Country
6.1 Europe Insulin Syringes Historic Market Size by Country
6.1.1 Europe Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insulin Syringes Sales in Volume by Country (2018-2023)
6.1.3 Europe Insulin Syringes Sales in Value by Country (2018-2023)
6.2 Europe Insulin Syringes Forecasted Market Size by Country
6.2.1 Europe Insulin Syringes Sales in Volume by Country (2024-2029)
6.2.2 Europe Insulin Syringes Sales in Value by Country (2024-2029)
7 Asia-Pacific Insulin Syringes by Region
7.1 Asia-Pacific Insulin Syringes Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Syringes Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insulin Syringes Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insulin Syringes Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insulin Syringes Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Syringes Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insulin Syringes Sales in Value by Region (2024-2029)
8 Latin America Insulin Syringes by Country
8.1 Latin America Insulin Syringes Historic Market Size by Country
8.1.1 Latin America Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insulin Syringes Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insulin Syringes Sales in Value by Country (2018-2023)
8.2 Latin America Insulin Syringes Forecasted Market Size by Country
8.2.1 Latin America Insulin Syringes Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insulin Syringes Sales in Value by Country (2024-2029)
9 Middle East and Africa Insulin Syringes by Country
9.1 Middle East and Africa Insulin Syringes Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insulin Syringes Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insulin Syringes Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insulin Syringes Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Syringes Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insulin Syringes Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novo Nordisk Insulin Syringes Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Insulin Syringes Products Offered
10.2.5 Sanofi Recent Development
10.3 Eli Lilly and Company
10.3.1 Eli Lilly and Company Company Information
10.3.2 Eli Lilly and Company Introduction and Business Overview
10.3.3 Eli Lilly and Company Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly and Company Insulin Syringes Products Offered
10.3.5 Eli Lilly and Company Recent Development
10.4 Biocon Ltd
10.4.1 Biocon Ltd Company Information
10.4.2 Biocon Ltd Introduction and Business Overview
10.4.3 Biocon Ltd Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Biocon Ltd Insulin Syringes Products Offered
10.4.5 Biocon Ltd Recent Development
10.5 Ypsomed AG
10.5.1 Ypsomed AG Company Information
10.5.2 Ypsomed AG Introduction and Business Overview
10.5.3 Ypsomed AG Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ypsomed AG Insulin Syringes Products Offered
10.5.5 Ypsomed AG Recent Development
10.6 Wockhardt Ltd
10.6.1 Wockhardt Ltd Company Information
10.6.2 Wockhardt Ltd Introduction and Business Overview
10.6.3 Wockhardt Ltd Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Wockhardt Ltd Insulin Syringes Products Offered
10.6.5 Wockhardt Ltd Recent Development
10.7 Medtronic Plc
10.7.1 Medtronic Plc Company Information
10.7.2 Medtronic Plc Introduction and Business Overview
10.7.3 Medtronic Plc Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Medtronic Plc Insulin Syringes Products Offered
10.7.5 Medtronic Plc Recent Development
10.8 Abbott Laboratories
10.8.1 Abbott Laboratories Company Information
10.8.2 Abbott Laboratories Introduction and Business Overview
10.8.3 Abbott Laboratories Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Abbott Laboratories Insulin Syringes Products Offered
10.8.5 Abbott Laboratories Recent Development
10.9 Animas Corporation
10.9.1 Animas Corporation Company Information
10.9.2 Animas Corporation Introduction and Business Overview
10.9.3 Animas Corporation Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Animas Corporation Insulin Syringes Products Offered
10.9.5 Animas Corporation Recent Development
10.10 F. Hoffmann-La Roche
10.10.1 F. Hoffmann-La Roche Company Information
10.10.2 F. Hoffmann-La Roche Introduction and Business Overview
10.10.3 F. Hoffmann-La Roche Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.10.4 F. Hoffmann-La Roche Insulin Syringes Products Offered
10.10.5 F. Hoffmann-La Roche Recent Development
10.11 BD
10.11.1 BD Company Information
10.11.2 BD Introduction and Business Overview
10.11.3 BD Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.11.4 BD Insulin Syringes Products Offered
10.11.5 BD Recent Development
10.12 Terumo Corporation
10.12.1 Terumo Corporation Company Information
10.12.2 Terumo Corporation Introduction and Business Overview
10.12.3 Terumo Corporation Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Terumo Corporation Insulin Syringes Products Offered
10.12.5 Terumo Corporation Recent Development
10.13 Cardinal Health Inc
10.13.1 Cardinal Health Inc Company Information
10.13.2 Cardinal Health Inc Introduction and Business Overview
10.13.3 Cardinal Health Inc Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Cardinal Health Inc Insulin Syringes Products Offered
10.13.5 Cardinal Health Inc Recent Development
10.14 Medline Industries
10.14.1 Medline Industries Company Information
10.14.2 Medline Industries Introduction and Business Overview
10.14.3 Medline Industries Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Medline Industries Insulin Syringes Products Offered
10.14.5 Medline Industries Recent Development
10.15 Braun Melunsun
10.15.1 Braun Melunsun Company Information
10.15.2 Braun Melunsun Introduction and Business Overview
10.15.3 Braun Melunsun Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Braun Melunsun Insulin Syringes Products Offered
10.15.5 Braun Melunsun Recent Development
10.16 Nipro Medical Corporation
10.16.1 Nipro Medical Corporation Company Information
10.16.2 Nipro Medical Corporation Introduction and Business Overview
10.16.3 Nipro Medical Corporation Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Nipro Medical Corporation Insulin Syringes Products Offered
10.16.5 Nipro Medical Corporation Recent Development
10.17 HMD Healthcare Ltd
10.17.1 HMD Healthcare Ltd Company Information
10.17.2 HMD Healthcare Ltd Introduction and Business Overview
10.17.3 HMD Healthcare Ltd Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
10.17.4 HMD Healthcare Ltd Insulin Syringes Products Offered
10.17.5 HMD Healthcare Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Syringes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Syringes Industrial Chain Analysis
11.4 Insulin Syringes Market Dynamics
11.4.1 Insulin Syringes Industry Trends
11.4.2 Insulin Syringes Market Drivers
11.4.3 Insulin Syringes Market Challenges
11.4.4 Insulin Syringes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Syringes Distributors
12.3 Insulin Syringes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock